PointState Capital’s Cubist Pharmaceuticals CBST Stock Holding History
Bought
Maintained
Sold
Other funds holding CBST
PointState Capital's CBST Position: Q4 2014 in Review
PointState Capital sold out of Cubist Pharmaceuticals (CBST) in Q4 2014, closing a stake of 1,650,000 shares — an estimated $109M sold.
PointState Capital first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $109M in Q3 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.
- PointState Capital reported no remaining Cubist Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
- PointState Capital sold 1,650,000 Cubist Pharmaceuticals shares in Q4 2014, an estimated $109M.
- PointState Capital first reported a position in Cubist Pharmaceuticals in Q2 2013 and held it in 6 quarters.
- PointState Capital's Cubist Pharmaceuticals position peaked at $109M in Q3 2014.
- 307 funds tracked by Wall St. Rank held Cubist Pharmaceuticals as of Q4 2014.
Based on PointState Capital's 13F filing for Q4 2014, filed 17 Feb 2015.